Vial amounts are not human doses
Is there a safe KLOW peptide dosage for people?
No human amount has been proved. The 80 mg on the vial only tells you how much of each peptide is inside.
The vial amount does not give you a safe dose
Is there a proved human amount? No. A sound study hasn't set a KLOW peptide dosage for people, and this page won't turn animal work into one.
The lab package holds 80 mg in all. It has GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg. Those are package contents, not an amount you can safely use.
Researchers studied each part on its own. Amount, test animal and way given all varied. You can't add such unlike figures to make one sound KLOW dose.
Your body handles each part at a separate pace. KPV or GHK-Cu may leave before BPC-157. These study facts don't give you a plan for human use.
Study amounts differ too much to add together
In lab work, KLOW peptide dosage starts with the vial label. The vial holds 80 mg: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg. Lab staff add germ-free water [1].
In cells, 10 picograms of thymosin beta-4, a natural wound protein, made skin cells move [1]. There are a trillion picograms in one gram, and this wasn't a human dose.
Rats got BPC-157 once a day at 10 micrograms, 10 nanograms or 10 picograms per animal, placed into the belly [2]. A microgram is a millionth of a gram; a nanogram, a billionth; and a picogram, a trillionth. KPV was tested at 10 nanomoles per liter in cells and 100 micromoles per liter in mouse drinking water [3]. Nanomoles and micromoles state the amount in liquid, not the weight of a vial. GHK-Cu was tested in tiny lab amounts and skin creams [4].
The animals and methods were too different to set a personal dose. The figures give you no single human amount. None came from a KLOW study.
GHK-Cu is the largest part of the 80 mg vial
GHK-Cu accounts for the largest share of the 80 mg vial. It supplies 50 mg, while BPC-157, TB-500 and KPV each supply 10 mg [1]. These are package amounts, not doses.
Copper in GHK-Cu may make the liquid light blue, but the color isn't a dye. All four peptides still remain separate.
Because KLOW is a mixture, it has no single lab identity of its own [1]. The four-peptide blend page and references page list BPC-157 and TB-500 with the other parts. Those records can't turn package amounts into a dose for you.
The four parts leave the body at different speeds
Each peptide breaks down on its own clock. BPC-157 may last longer than KPV and GHK-Cu. The TB-500 piece also acts differently from thymosin beta-4, the whole wound-healing protein [1].
After one use, their levels won't stay matched for long. A slower part may remain after faster parts are gone. No study shows what that gap means for benefit or harm.
A single amount therefore can't make the parts move in step. Claims that the blend works as a team remain unproved. Remember that when you see a dose claim.
Human studies do not supply a blend dose
No human dose study covers the four-part blend [1]. People have been in GHK-Cu skin and wound studies. KPV and thymosin beta-4, the natural protein behind TB-500, have other early work, but none sets a KLOW dose.
The BPC-157 safety test was very small. In 2025, two healthy adults received 10 mg on day 1 and 20 mg on day 2 without a reported problem [8]. That still cannot set a KLOW dose.
Human KPV tests studied delivery, meaning how KPV enters the body, rather than whether people improved [1]. We cite that work to show what was tested. It can't supply a safe amount for the KLOW blend.